Gastritis diagnostic test: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: Removing from Primary care)
 
(4 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
The nonendoscopic diagnostic testing methods for Gastritis associated with ''[[H. pylori]]'' include antibody tests, urea breath test, and fecal antigen test.
The non-endoscopic diagnostic testing methods for gastritis associated with ''[[H. pylori]]'' include antibody tests, [[urea breath test]], and fecal antigen test.


==Nonendoscopic diagnostic studies==
==Non-endoscopic diagnostic studies==
The non-endoscopic diagnostic testing methods for ''[[H. pylori]] include:''
*Antibody tests
*[[Urea breath test]] (UBT)
*Fecal antigen test
{| class="wikitable"  
{| class="wikitable"  
| colspan="4" |
| colspan="4" style="background:#DCDCDC; + " |
*[[Antibody]] testing is inexpensive and widely available but poor PPV in populations with a low [[prevalence]] of ''[[H. pylori]]'' infection limits its usefulness in clinical practice.
*[[Antibody]] testing is inexpensive and widely available but a poor [[positive predictive value]] (PPV) in populations with a low [[prevalence]] of ''[[H. pylori]]'' infection limits its usefulness in clinical practice.
|-  
|-  
| colspan="4" |
| colspan="4" style="background:#DCDCDC; + " |
*The UBTs and fecal antigen tests provide reliable means of identifying active ''[[H. pylori]]'' infection before antibiotic therapy.  
*The UBT and fecal antigen tests provide reliable means of identifying active ''[[H. pylori]]'' infection before antibiotic therapy.  
|-  
|-  
| colspan="4" |
| colspan="4" style="background:#DCDCDC; + " |
*The UBT is the most reliable non endoscopic test to document eradication of ''[[H. pylori]]'' infection.  
*The UBT is the most reliable non endoscopic test to document eradication of ''[[H. pylori]]'' infection.  
|-  
|-  
| colspan="4" |
| colspan="4" style="background:#DCDCDC; + " |
*The monoclonal fecal antigen test provides another nonendoscopic means of establishing ''[[H. pylori]]'' cure after antibiotic treatment.  
*The monoclonal fecal antigen test provides another non-endoscopic means of establishing ''[[H. pylori]]'' cure after antibiotic treatment.  
|-  
|-  
| colspan="4" |
| colspan="4" style="background:#DCDCDC; + " |
*Testing to prove ''[[H. pylori]]'' eradication appears to be most accurate if performed at least 4 wk after the completion of [[antibiotic therapy]].  
*Testing to prove ''[[H. pylori]]'' eradication appears to be most accurate if performed at least 4 wk after the completion of [[antibiotic therapy]].  
|}
|}
The nonendoscopic diagnostic testing methods for ''[[H. pylori]] include:
*Antibody tests
*Urea breath test
*Fecal antigen test


===Antibody tests===
===Antibody tests===
*Antibody testing depends on the detection of ''[[H. pylori]]'' specific [[IgG]] antibodies in [[serum]], [[whole blood]], or [[urine]].<ref name="pmid11190069">{{cite journal| author=Ho B, Marshall BJ| title=Accurate diagnosis of Helicobacter pylori. Serologic testing. | journal=Gastroenterol Clin North Am | year= 2000 | volume= 29 | issue= 4 | pages= 853-62 | pmid=11190069 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11190069  }} </ref><ref name="pmid8651160">{{cite journal| author=Loy CT, Irwig LM, Katelaris PH, Talley NJ| title=Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. | journal=Am J Gastroenterol | year= 1996 | volume= 91 | issue= 6 | pages= 1138-44 | pmid=8651160 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8651160  }} </ref><ref name="pmid10364016">{{cite journal| author=Chey WD, Murthy U, Shaw S, Zawadski A, Montague J, Linscheer W et al.| title=A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial. | journal=Am J Gastroenterol | year= 1999 | volume= 94 | issue= 6 | pages= 1512-6 | pmid=10364016 | doi=10.1111/j.1572-0241.1999.1135_x.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10364016  }} </ref>
*Antibody testing depends on the detection of ''[[H. pylori]]'' specific [[IgG]] antibodies in [[serum]], [[whole blood]], or [[urine]].<ref name="pmid11190069">{{cite journal| author=Ho B, Marshall BJ| title=Accurate diagnosis of Helicobacter pylori. Serologic testing. | journal=Gastroenterol Clin North Am | year= 2000 | volume= 29 | issue= 4 | pages= 853-62 | pmid=11190069 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11190069  }} </ref><ref name="pmid8651160">{{cite journal| author=Loy CT, Irwig LM, Katelaris PH, Talley NJ| title=Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. | journal=Am J Gastroenterol | year= 1996 | volume= 91 | issue= 6 | pages= 1138-44 | pmid=8651160 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8651160  }} </ref><ref name="pmid10364016">{{cite journal| author=Chey WD, Murthy U, Shaw S, Zawadski A, Montague J, Linscheer W et al.| title=A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial. | journal=Am J Gastroenterol | year= 1999 | volume= 94 | issue= 6 | pages= 1512-6 | pmid=10364016 | doi=10.1111/j.1572-0241.1999.1135_x.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10364016  }} </ref>
*The [[IgG]] antibodies typically become detected 21 days after [[infection]] and can remain present long after eradication.
*The [[IgG]] antibodies typically become detected 21 days after [[infection]] and can remain present long after eradication.
*[[Antibodies]] are detected using [[enzyme-linked immunosorbent assay|enzyme-linked immunosorbent assay (ELISA)]] and [[latex agglutination]] techniques.
*[[Antibodies]] are detected using [[enzyme-linked immunosorbent assay|enzyme-linked immunosorbent assay (ELISA)]] and [[Latex agglutination test|latex agglutination]] techniques.


===Urea Breath Tests===
===Urea Breath Test (UBT)===
*Urea breath test identifies active ''[[H. pylori]]'' infection.<ref name="pmid15569102">{{cite journal| author=Gisbert JP, Pajares JM| title=Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. | journal=Aliment Pharmacol Ther | year= 2004 | volume= 20 | issue= 10 | pages= 1001-17 | pmid=15569102 | doi=10.1111/j.1365-2036.2004.02203.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15569102  }} </ref><ref name="pmid11190074">{{cite journal| author=Chey WD| title=Accurate diagnosis of Helicobacter pylori. 14C-urea breath test. | journal=Gastroenterol Clin North Am | year= 2000 | volume= 29 | issue= 4 | pages= 895-902 | pmid=11190074 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11190074  }} </ref>
*[[Urea breath test]] identifies active ''[[H. pylori]]'' infection.<ref name="pmid15569102">{{cite journal| author=Gisbert JP, Pajares JM| title=Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. | journal=Aliment Pharmacol Ther | year= 2004 | volume= 20 | issue= 10 | pages= 1001-17 | pmid=15569102 | doi=10.1111/j.1365-2036.2004.02203.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15569102  }} </ref><ref name="pmid11190074">{{cite journal| author=Chey WD| title=Accurate diagnosis of Helicobacter pylori. 14C-urea breath test. | journal=Gastroenterol Clin North Am | year= 2000 | volume= 29 | issue= 4 | pages= 895-902 | pmid=11190074 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11190074  }} </ref>
*'''Procedure'''
*'''Procedure'''
:*The urea labeled with either the nonradioactive isotope 13C or the radioactive isotope 14C is ingested.
:*The [[urea]] labeled with either the nonradioactive isotope <sup>13</sup>C or the radioactive isotope <sup>14</sup>C is ingested.
:*The H.pylori urease converts labeled urea to CO2, which can be quantitated in expired breath.
:*The ''[[H. pylori]]'' [[urease]] converts labeled [[urea]] to [[CO2|CO<sub>2</sub>]], which can be quantitated in expired breath.
*13C labeled urea is preferred in children and pregnant females.
*<sup>13</sup>C labeled [[urea]] is preferred in children and pregnant females.
*The urea breath test has 95% sensitivity and specificity.<ref name="pmid8540496">{{cite journal| author=Steen T, Berstad K, Meling T, Berstad A| title=Reproducibility of the 14C urea breath test repeated after 1 week. | journal=Am J Gastroenterol | year= 1995 | volume= 90 | issue= 12 | pages= 2103-5 | pmid=8540496 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8540496  }} </ref>
*The [[urea breath test]] has 95% [[sensitivity]] and [[specificity]].<ref name="pmid8540496">{{cite journal| author=Steen T, Berstad K, Meling T, Berstad A| title=Reproducibility of the 14C urea breath test repeated after 1 week. | journal=Am J Gastroenterol | year= 1995 | volume= 90 | issue= 12 | pages= 2103-5 | pmid=8540496 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8540496  }} </ref>
*This test is an accurate means of post-treatment testing.<ref name="pmid10445534">{{cite journal| author=Leodolter A, Domínguez-Muñoz JE, von Arnim U, Kahl S, Peitz U, Malfertheiner P| title=Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. | journal=Am J Gastroenterol | year= 1999 | volume= 94 | issue= 8 | pages= 2100-4 | pmid=10445534 | doi=10.1111/j.1572-0241.1999.01284.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10445534  }} </ref><ref name="pmid12425544">{{cite journal| author=Perri F, Manes G, Neri M, Vaira D, Nardone G| title=Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 11 | pages= 2756-62 | pmid=12425544 | doi=10.1111/j.1572-0241.2002.07065.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12425544  }} </ref>
*This test is an accurate means of post-treatment testing.<ref name="pmid10445534">{{cite journal| author=Leodolter A, Domínguez-Muñoz JE, von Arnim U, Kahl S, Peitz U, Malfertheiner P| title=Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. | journal=Am J Gastroenterol | year= 1999 | volume= 94 | issue= 8 | pages= 2100-4 | pmid=10445534 | doi=10.1111/j.1572-0241.1999.01284.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10445534  }} </ref><ref name="pmid12425544">{{cite journal| author=Perri F, Manes G, Neri M, Vaira D, Nardone G| title=Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 11 | pages= 2756-62 | pmid=12425544 | doi=10.1111/j.1572-0241.2002.07065.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12425544  }} </ref>
*As this test mainly depends on [[urease]] activity of ''[[H. pylori]], the sensitivity of the test is decreased by medications such as [[bismuth]] containing products, [[proton pump inhibitor|PPIs]], and [[antibiotics]] as they reduce organism density or [[urease]] activity. It is recommended to withhold [[proton pump inhibitor|PPIs]] for 7-14 days prior to the test, and bismuth and antibiotics are withheld for at least 28 days.<ref name="pmid12809820">{{cite journal| author=Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS et al.| title=Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. | journal=Am J Gastroenterol | year= 2003 | volume= 98 | issue= 5 | pages= 1005-9 | pmid=12809820 | doi=10.1111/j.1572-0241.2003.07426.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12809820  }} </ref><ref name="pmid9068466">{{cite journal| author=Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J| title=Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. | journal=Am J Gastroenterol | year= 1997 | volume= 92 | issue= 3 | pages= 446-50 | pmid=9068466 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9068466  }} </ref><ref name="pmid9758575">{{cite journal| author=Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB| title=Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. | journal=Ann Intern Med | year= 1998 | volume= 129 | issue= 7 | pages= 547-50 | pmid=9758575 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9758575  }} </ref>  
*As this test mainly depends on [[urease]] activity of ''[[H. pylori]], ''the [[sensitivity]] of the test is decreased by medications such as [[bismuth]] containing products, [[proton pump inhibitor|PPIs]], and [[antibiotics]] as they reduce organism density or [[urease]] activity. It is recommended to withhold [[proton pump inhibitor|PPIs]] for 7-14 days prior to the test, and bismuth and antibiotics are withheld for at least 28 days.<ref name="pmid12809820">{{cite journal| author=Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS et al.| title=Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. | journal=Am J Gastroenterol | year= 2003 | volume= 98 | issue= 5 | pages= 1005-9 | pmid=12809820 | doi=10.1111/j.1572-0241.2003.07426.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12809820  }} </ref><ref name="pmid9068466">{{cite journal| author=Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J| title=Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. | journal=Am J Gastroenterol | year= 1997 | volume= 92 | issue= 3 | pages= 446-50 | pmid=9068466 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9068466  }} </ref><ref name="pmid9758575">{{cite journal| author=Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB| title=Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. | journal=Ann Intern Med | year= 1998 | volume= 129 | issue= 7 | pages= 547-50 | pmid=9758575 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9758575  }} </ref>  
*[[Antacids]] do not affect the efficacy of the test.<ref name="pmid15128344">{{cite journal| author=Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F et al.| title=Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. | journal=Am J Gastroenterol | year= 2004 | volume= 99 | issue= 5 | pages= 823-9 | pmid=15128344 | doi=10.1111/j.1572-0241.2004.30162.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15128344  }} </ref>
*[[Antacids]] do not affect the efficacy of the test.<ref name="pmid15128344">{{cite journal| author=Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F et al.| title=Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. | journal=Am J Gastroenterol | year= 2004 | volume= 99 | issue= 5 | pages= 823-9 | pmid=15128344 | doi=10.1111/j.1572-0241.2004.30162.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15128344  }} </ref>


Line 48: Line 47:
*The [[fecal antigen test|fecal antigen test (FAT)]] is an [[enzyme immunoassay]] which identifies ''[[H. pylori]]'' antigen with the use of [[polyclonal]] anti-H.pylori antibody.<ref name="pmid15270750">{{cite journal| author=Gisbert JP, Pajares JM| title=Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. | journal=Helicobacter | year= 2004 | volume= 9 | issue= 4 | pages= 347-68 | pmid=15270750 | doi=10.1111/j.1083-4389.2004.00235.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15270750  }} </ref><ref name="pmid16780557">{{cite journal| author=Gisbert JP, de la Morena F, Abraira V| title=Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. | journal=Am J Gastroenterol | year= 2006 | volume= 101 | issue= 8 | pages= 1921-30 | pmid=16780557 | doi=10.1111/j.1572-0241.2006.00668.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16780557  }} </ref>
*The [[fecal antigen test|fecal antigen test (FAT)]] is an [[enzyme immunoassay]] which identifies ''[[H. pylori]]'' antigen with the use of [[polyclonal]] anti-H.pylori antibody.<ref name="pmid15270750">{{cite journal| author=Gisbert JP, Pajares JM| title=Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. | journal=Helicobacter | year= 2004 | volume= 9 | issue= 4 | pages= 347-68 | pmid=15270750 | doi=10.1111/j.1083-4389.2004.00235.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15270750  }} </ref><ref name="pmid16780557">{{cite journal| author=Gisbert JP, de la Morena F, Abraira V| title=Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. | journal=Am J Gastroenterol | year= 2006 | volume= 101 | issue= 8 | pages= 1921-30 | pmid=16780557 | doi=10.1111/j.1572-0241.2006.00668.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16780557  }} </ref>
*[[Monoclonal antibodies]] can also be used to identify fecal ''[[H. pylori]]'' antigens.
*[[Monoclonal antibodies]] can also be used to identify fecal ''[[H. pylori]]'' antigens.
*Both tests are used to screen for infection and post-treatment testing.
*Both tests are used to screen for [[infection]] and post-treatment testing.
*The fecal antigen test is approved by U.S Food and Drug Administration as an alternative means of establishing ''[[H. pylori]]'' cure to urea breath test.
*The fecal antigen test is approved by [[Food and Drug Administration|U.S Food and Drug Administration]] as an alternative means of establishing ''[[H. pylori]]'' cure to [[urea breath test]].
*The polyclonal test has excellent sensitivity, specificity, and predictive values before treatment but less satisfactory after the treatment.
*The polyclonal test has excellent [[sensitivity]], [[specificity]], and predictive values before treatment but less satisfactory after the treatment.
*This test may be effective in confirming eradication of ''[[H. pylori]]'' infection as early as 14 days after treatment. However, it is suggested that it should be done more than 4 wk and up to 8-12 wk after ''[[H. pylori]]'' treatment.<ref name="pmid11848725">{{cite journal| author=Vaira D, Vakil N, Menegatti M, van't Hoff B, Ricci C, Gatta L et al.| title=The stool antigen test for detection of Helicobacter pylori after eradication therapy. | journal=Ann Intern Med | year= 2002 | volume= 136 | issue= 4 | pages= 280-7 | pmid=11848725 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11848725  }} </ref><ref name="pmid15270750">{{cite journal| author=Gisbert JP, Pajares JM| title=Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. | journal=Helicobacter | year= 2004 | volume= 9 | issue= 4 | pages= 347-68 | pmid=15270750 | doi=10.1111/j.1083-4389.2004.00235.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15270750  }} </ref>
*This test may be effective in confirming eradication of ''[[H. pylori]]'' infection as early as 14 days after treatment. However, it is suggested that it should be done more than 4 wk and up to 8-12 wk after ''[[H. pylori]]'' treatment.<ref name="pmid11848725">{{cite journal| author=Vaira D, Vakil N, Menegatti M, van't Hoff B, Ricci C, Gatta L et al.| title=The stool antigen test for detection of Helicobacter pylori after eradication therapy. | journal=Ann Intern Med | year= 2002 | volume= 136 | issue= 4 | pages= 280-7 | pmid=11848725 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11848725  }} </ref><ref name="pmid15270750">{{cite journal| author=Gisbert JP, Pajares JM| title=Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. | journal=Helicobacter | year= 2004 | volume= 9 | issue= 4 | pages= 347-68 | pmid=15270750 | doi=10.1111/j.1083-4389.2004.00235.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15270750  }} </ref>
*The sensitivity of the test is affected by the use of [[proton pump inhibitors|PPIs]], [[bismuth|bismuth compounds]], and [[antibiotics]]. The specificity is affected by the bleeding [[peptic ulcer disease]].<ref name="pmid11922552">{{cite journal| author=Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F| title=Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 3 | pages= 594-9 | pmid=11922552 | doi=10.1111/j.1572-0241.2002.05535.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11922552  }} </ref>
*The [[sensitivity]] of the test is affected by the use of [[proton pump inhibitors|PPIs]], [[bismuth|bismuth compounds]], and [[antibiotics]]. The [[specificity]] is affected by the bleeding [[peptic ulcer disease]].<ref name="pmid11922552">{{cite journal| author=Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F| title=Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 3 | pages= 594-9 | pmid=11922552 | doi=10.1111/j.1572-0241.2002.05535.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11922552  }} </ref>


{| class="wikitable"
{| class="wikitable"
Line 59: Line 58:
! style="background:#4479BA; color: #FFFFFF;" + | Disadvantages
! style="background:#4479BA; color: #FFFFFF;" + | Disadvantages
|-
|-
| style="background:#DCDCDC; + | 1. [[ELISA]] serology
| style="background:#DCDCDC; + " | '''1. [[ELISA]] serology'''
(quantitative and qualitative)
'''(quantitative and qualitative)'''
|
|
* Inexpensive and widely available
* Inexpensive and widely available
* Very good NPV
* Very good [[negative predictive value]] (NPV)
* Sensitivity (85-92%) and specificity (70-83%)
* [[Sensitivity]] (85-92%) and [[specificity]] (70-83%)
|
|
* PPV dependent upon background ''[[H. pylori]]'' prevalence.  
* PPV dependent upon background [[H. pylori|''H. pylori'']] prevalence.  
* ''Not recommended after ''[[H. pylori]]'' therapy
* Not recommended after [[H. pylori|''H. pylori'']] therapy
* Less accurate and does not identify infection
* Less accurate and does not identify [[infection]]
|-
|-
| style="background:#DCDCDC; + | *2. Urea breath tests (13C and 14C)
| style="background:#DCDCDC; + " | '''2. Urea breath tests (13C and 14C)'''
|
|
* Identifies active ''[[H. pylori]]'' infection.
* Identifies active ''[[H. pylori]]'' infection
* Excellent PPV and NPV regardless of ''[[H. pylori]]'' prevalence.
* Excellent PPV and NPV regardless of ''[[H. pylori]]'' prevalence  
* Useful before and after ''[[H. pylori]]'' therapy
* Useful before and after ''[[H. pylori]]'' therapy
* Sensitivity (95%) and specificity (96%)
* [[Sensitivity]] (95%) and [[specificity]] (96%)
|
|
* Reimbursement and availability remain inconsistent
* Reimbursement and availability remain inconsistent
|-
|-
| style="background:#DCDCDC; + | *3. Fecal antigen test
| style="background:#DCDCDC; + " | '''3. Fecal antigen test'''
|
|
* Identifies active ''[[H. pylori]]'' infection.  
* Identifies active ''[[H. pylori]]'' infection.  
* Excellent positive and negative predictive values regardless of ''[[H. pylori]]'' prevalence.
* Excellent PPV and NPV regardless of ''[[H. pylori]]'' prevalence  
* Useful before and after ''[[H. pylori]]'' therapy
* Useful before and after ''[[H. pylori]]'' therapy
* Sensitivity (95%) and specificity (94%)
* [[Sensitivity]] (95%) and [[specificity]] (94%)
|
|
* Polyclonal test less well validated than the UBT in the post treatment setting.
* Polyclonal test less well validated than the UBT in the post-treatment setting  


* The monoclonal test appears reliable before and after [[antibiotic]] therapy.
* The monoclonal test appears reliable before and after [[antibiotic]] therapy  
* Unpleasantness associated with collecting stool
* Unpleasantness associated with collecting stool
|}
|}
Line 94: Line 93:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
​​​
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Up-To-Date]]

Latest revision as of 21:49, 29 July 2020

Gastritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gastritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Diagnostic tests

Endoscopic tests
Nonendoscopic tests

X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastritis diagnostic test On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastritis diagnostic test

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastritis diagnostic test

CDC on Gastritis diagnostic test

Gastritis diagnostic test in the news

Blogs on Gastritis diagnostic test

Directions to Hospitals Treating Gastritis

Risk calculators and risk factors for Gastritis diagnostic test

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

The non-endoscopic diagnostic testing methods for gastritis associated with H. pylori include antibody tests, urea breath test, and fecal antigen test.

Non-endoscopic diagnostic studies

The non-endoscopic diagnostic testing methods for H. pylori include:

  • The UBT and fecal antigen tests provide reliable means of identifying active H. pylori infection before antibiotic therapy.
  • The UBT is the most reliable non endoscopic test to document eradication of H. pylori infection.
  • The monoclonal fecal antigen test provides another non-endoscopic means of establishing H. pylori cure after antibiotic treatment.
  • Testing to prove H. pylori eradication appears to be most accurate if performed at least 4 wk after the completion of antibiotic therapy.

Antibody tests

Urea Breath Test (UBT)

  • The urea labeled with either the nonradioactive isotope 13C or the radioactive isotope 14C is ingested.
  • The H. pylori urease converts labeled urea to CO2, which can be quantitated in expired breath.

Fecal Antigen Test (FAT)

Nonendoscopic testing Advantages Disadvantages
1. ELISA serology

(quantitative and qualitative)

  • PPV dependent upon background H. pylori prevalence.
  • Not recommended after H. pylori therapy
  • Less accurate and does not identify infection
2. Urea breath tests (13C and 14C)
  • Reimbursement and availability remain inconsistent
3. Fecal antigen test
  • Polyclonal test less well validated than the UBT in the post-treatment setting
  • The monoclonal test appears reliable before and after antibiotic therapy
  • Unpleasantness associated with collecting stool

References

  1. ↑ Ho B, Marshall BJ (2000). "Accurate diagnosis of Helicobacter pylori. Serologic testing". Gastroenterol Clin North Am. 29 (4): 853–62. PMID 11190069.
  2. ↑ Loy CT, Irwig LM, Katelaris PH, Talley NJ (1996). "Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis". Am J Gastroenterol. 91 (6): 1138–44. PMID 8651160.
  3. ↑ Chey WD, Murthy U, Shaw S, Zawadski A, Montague J, Linscheer W; et al. (1999). "A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial". Am J Gastroenterol. 94 (6): 1512–6. doi:10.1111/j.1572-0241.1999.1135_x.x. PMID 10364016.
  4. ↑ Gisbert JP, Pajares JM (2004). "Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review". Aliment Pharmacol Ther. 20 (10): 1001–17. doi:10.1111/j.1365-2036.2004.02203.x. PMID 15569102.
  5. ↑ Chey WD (2000). "Accurate diagnosis of Helicobacter pylori. 14C-urea breath test". Gastroenterol Clin North Am. 29 (4): 895–902. PMID 11190074.
  6. ↑ Steen T, Berstad K, Meling T, Berstad A (1995). "Reproducibility of the 14C urea breath test repeated after 1 week". Am J Gastroenterol. 90 (12): 2103–5. PMID 8540496.
  7. ↑ Leodolter A, Domínguez-Muñoz JE, von Arnim U, Kahl S, Peitz U, Malfertheiner P (1999). "Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting". Am J Gastroenterol. 94 (8): 2100–4. doi:10.1111/j.1572-0241.1999.01284.x. PMID 10445534.
  8. ↑ Perri F, Manes G, Neri M, Vaira D, Nardone G (2002). "Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments". Am J Gastroenterol. 97 (11): 2756–62. doi:10.1111/j.1572-0241.2002.07065.x. PMID 12425544.
  9. ↑ Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS; et al. (2003). "Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors". Am J Gastroenterol. 98 (5): 1005–9. doi:10.1111/j.1572-0241.2003.07426.x. PMID 12809820.
  10. ↑ Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J (1997). "Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism". Am J Gastroenterol. 92 (3): 446–50. PMID 9068466.
  11. ↑ Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB (1998). "Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori". Ann Intern Med. 129 (7): 547–50. PMID 9758575.
  12. ↑ Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F; et al. (2004). "Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection". Am J Gastroenterol. 99 (5): 823–9. doi:10.1111/j.1572-0241.2004.30162.x. PMID 15128344.
  13. ↑ 13.0 13.1 Gisbert JP, Pajares JM (2004). "Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review". Helicobacter. 9 (4): 347–68. doi:10.1111/j.1083-4389.2004.00235.x. PMID 15270750.
  14. ↑ Gisbert JP, de la Morena F, Abraira V (2006). "Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis". Am J Gastroenterol. 101 (8): 1921–30. doi:10.1111/j.1572-0241.2006.00668.x. PMID 16780557.
  15. ↑ Vaira D, Vakil N, Menegatti M, van't Hoff B, Ricci C, Gatta L; et al. (2002). "The stool antigen test for detection of Helicobacter pylori after eradication therapy". Ann Intern Med. 136 (4): 280–7. PMID 11848725.
  16. ↑ Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F (2002). "Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy". Am J Gastroenterol. 97 (3): 594–9. doi:10.1111/j.1572-0241.2002.05535.x. PMID 11922552.

​​​

Retrieved from "https://www.wikidoc.org/index.php?title=Gastritis_diagnostic_test&oldid=1638398"